Search clinical trials for: Hemorrhagic Cystitis

Total 6910 results

Wuhan Union Hospital, China

Not yet recruiting

Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT

Hematopoietic Stem Cell Transplantation | Treatment | Hemorrhagic Cystitis | Moxibustion
Wuhan Union Hospital, China

Not yet recruiting

Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT

Hematopoietic Stem Cell Transplantation | Prevention | Hemorrhagic Cystitis | Moxibustion
Centre Hospitalier Universitaire Vaudois
Hôpital Riviera-Chablais, Vaud-Valais; Insel Gruppe AG, University Hospital...

Recruiting

The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) (INCyst)

Endometriosis | Bladder Cancer | Interstitial Cystitis | Neurogenic Bladder | Bladder Disease | Painful Bladder Syndrome | Hemorrhagic Cystitis

Switzerland
Tata Memorial Centre
Bhabha Atomic Research Centre (BARC), Mumbai

Recruiting

Chlorophyllin Tablets for Urinary Bleeding Following Radiation Therapy for Cancers of Pelvic Organs (CLARITY)

Hemorrhagic Cystitis

India
LIDDE Therapeutics

Recruiting

Tolerability and Efficacy of INSTYLAN in Subjects With Moderate to Severe Hemorrhagic Cystitis

Hemorrhagic Cystitis

France
Shandong Provincial Hospital

Recruiting

Hyperbaric Oxygen Therapy for Hemorrhagic Cystitis Post HSCT

Stem Cell Transplant Complications

China
Assistance Publique - Hôpitaux de Paris

Recruiting

Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy (PRISME)

Pelvic Radiation Therapy | Radiation-induced Hemorrhagic Cystitis

France
AlloVir

Terminated

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

BK Virus Infection | Hemorrhagic Cystitis

Korea, Republic of, United States, Italy, Sweden, United Kingdom, Spain, France
M.D. Anderson Cancer Center

Active, not recruiting

Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis

Transplantation Infection

United States
Lipella Pharmaceuticals, Inc.

Completed

The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis

Hemorrhagic Cystitis

United States
M.D. Anderson Cancer Center
Gilead Sciences

Withdrawn

Cidofovir Instillation in Hematopoietic Stem Cell Transplant (HSCT) Recipients With Hemorrhagic Cystitis

Cystitis | Bladder Diseases
M.D. Anderson Cancer Center
Gilead Sciences

Completed

Intravesical Cidofovir for Hemorrhagic Cystitis

Blood And Marrow Transplantation

United States
Karolinska Institutet

Unknown

A Double Blind Randomized Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis

Stem Cell Transplantation | Hemorrhagic Cystitis | Decidual Stromal Cells

Sweden
Karolinska Institutet

Completed

A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis

Hemorrhagic Cystitis

Sweden
University of Zurich
University Hospital, Geneva; Centre Hospitalier Universitaire Vaudois; University... and other collaborators

Not yet recruiting

SWIFT - SWIss Factor XIII Trial in PPH (SWIFT)

Hemorrhage | Coagulation Disorder | Postpartum Hemorrhage | Postpartum Complication | Coagulation Factor Deficiency

Switzerland
University Medical Center Groningen

Not yet recruiting

Bleeding in Multiple Myeloma (BiMM)

Multiple Myeloma
Yunfeng Cheng
Shanghai Zhongshan Hospital; Shanghai Jinshan Hospital; Macau University of Science... and other collaborators

Recruiting

The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP

Immune Thrombocytopenia With Positive ANA Antibodies

China, Hong Kong, Macau
Yunfeng Cheng
Shanghai Zhongshan Hospital; Shanghai Jinshan Hospital; Macau University of Science... and other collaborators

Recruiting

The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP

Immune Thrombocytopenia With Positive ANA Antibodies

China, Hong Kong, Macau
Pfizer

Not yet recruiting

Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.

Relapsed and Refractory Multiple Myeloma (RRMM)
Yunfeng Cheng
Shanghai Zhongshan Hospital; Shanghai Jinshan Hospital; Macau University of Science... and other collaborators

Recruiting

The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP

Immune Thrombocytopenia With Positive ANA Antibodies

China, Hong Kong, Macau
Peking Union Medical College Hospital

Recruiting

TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination

Immune Thrombocytopenia

China
Universitaire Ziekenhuizen KU Leuven
Janssen Pharmaceutica

Not yet recruiting

Study on the Clinical Efficacy of Teclistamab (TECTONIC)

Hematologic Diseases | Multiple Myeloma

Belgium
The First Affiliated Hospital with Nanjing Medical...
Nanjing Legend Biotech Co.

Not yet recruiting

LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

China
Centre Hospitalier Universitaire de Saint Etienne

Not yet recruiting

Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma (ProApix)

Multiple Myeloma | Total Knee Replacement

France
Janssen-Cilag Ltd.

Recruiting

A Real-world Study in Participants With Smoldering Multiple Myeloma

Smoldering Multiple Myeloma

France
Gruppo Italiano Malattie EMatologiche dell'Adulto

Not yet recruiting

Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

Primary Immune Thrombocytopenia
First Affiliated Hospital of Zhejiang University
First Affiliated Hospital of Wenzhou Medical University; The Affiliated Hospital... and other collaborators

Recruiting

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

Multiple Myeloma | Minimal Residual Disease

China
Nanjing IASO Biotechnology Co., Ltd.

Recruiting

A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03) (FUMANBA-03)

Multiple Myeloma

China
National Cancer Institute (NCI)

Not yet recruiting

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Hard-to-Treat Multiple Myeloma

Multiple Myeloma
Inozyme Pharma

Not yet recruiting

ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency

Pseudoxanthoma Elasticum | Arterial Calcification | Gene Mutations | Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency | Autosomal Recessive Hypophosphatemic Rickets Type 2
Stanford University
Janssen, LP

Not yet recruiting

Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma

Multiple Myeloma | Post Stem Cell Transplant

United States
Takeda

Recruiting

A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A

Acquired Hemophilia A

Japan
Merck Sharp & Dohme LLC

Not yet recruiting

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

Essential Thrombocythemia
Assiut University

Not yet recruiting

Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients

Multiple Myeloma
University Health Network, Toronto
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...

Not yet recruiting

TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study (T-REX HMB)

Venous Thromboembolism | Venous Thromboses | Anticoagulants and Bleeding Disorders | Heavy Menstrual Bleeding
Durham VA Medical Center
Duke University

Not yet recruiting

Telehealth-based Symptom Management for Veterans Treated With Selinexor (Selinexor)

Multiple Myeloma | Large-cell Lymphoma
Association APPROCHE
Société Neuradom; IMT Atlantique Brest

Recruiting

Impact of a Self-rehabilitation and Tele-rehabilitation Program on the Post-stroke Care Pathway (AUTONHOME)

Ischemic Stroke | Hemorrhagic Unilateral Cortico-subcortical Hemispheric Stroke

France
University Hospital, Bordeaux

Not yet recruiting

Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer (MATAC)

Neoplasms | Cancer | Immune Thrombocytopenia | Immune Thrombocytopenic Purpura

France
Fondazione Italiana Linfomi - ETS

Not yet recruiting

Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's Macroglobulinemia (WM) Treated in Italy According to the Zanubrutinib (Brukinsa®) Compassionate Use Program (CUP) and in Common Practice Following Commercial Approval.

Waldenström's Macroglobulinemia (WM)

Italy
Opna Bio LLC

Not yet recruiting

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

Refractory Multiple Myeloma | Relapsed Multiple Myeloma

United States
Shenzhen Geno-Immune Medical Institute
The No.2 Clinical Hospital of the Ministry of Health

Recruiting

Engineered Dendritic Cell Vaccines for Multiple Myeloma

Multiple Myeloma or Plasmacytoma

China, Russian Federation
Octapharma

Not yet recruiting

Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure

Significant Bleeding Risk | Vitamin K-Dependent Coagulation Defect
Shenzhen Geno-Immune Medical Institute
The No.2 Clinical Hospital of the Ministry of Health

Recruiting

Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma

Multiple Myeloma | Plasmacytoma

China, Russian Federation
Janssen Research & Development, LLC

Recruiting

A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma (MajesTEC-10)

Relapsed or Refractory Multiple Myeloma

Korea, Republic of, United States, Australia
Alicia Martínez Piñeiro

Recruiting

BraiN20® Medical Device in Suspected Acute Stroke Patients (PROMISE-GLOB)

Acute Stroke

Spain
Ontario Clinical Oncology Group (OCOG)
Pfizer

Not yet recruiting

Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma (EMBRACE)

Refractory Multiple Myeloma

Canada
Mahidol University

Not yet recruiting

Dengue Vaccine Hesitancy Among International Travelers

Vaccine Hesitancy
Nantes University Hospital

Not yet recruiting

Evaluation of a Range of Dermo-cosmetic Products to Treat Skin and Nail Toxicity Linked to Bispecific Anti-GPRC5D Bispecific Antibodies in Multiple Myeloma Patients". Myeloma". Descriptive Pilot Study (DELICATESSE)

Myeloma Multiple
PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Not yet recruiting

Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Systemic Sclerosis | Immune Thrombocytopenia | Sjogren's Syndrome | Idiopathic Inflammatory Myopathies | Primary Biliary Cholangitis
Kite, A Gilead Company
Arcellx, Inc.

Not yet recruiting

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma (iMMagine-3)

Multiple Myeloma

Search clinical trials for: Hemorrhagic Cystitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations